ClearPoint Neuro Inc (CLPT)
11.84
+0.74
(+6.72%)
USD |
NASDAQ |
Nov 22, 16:00
11.83
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Free Cash Flow: -9.076M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | -9.076M |
June 30, 2024 | -9.896M |
March 31, 2024 | -12.79M |
December 31, 2023 | -14.77M |
September 30, 2023 | -16.73M |
June 30, 2023 | -19.18M |
March 31, 2023 | -18.68M |
December 31, 2022 | -17.31M |
September 30, 2022 | -17.58M |
June 30, 2022 | -16.52M |
March 31, 2022 | -15.15M |
December 31, 2021 | -12.86M |
September 30, 2021 | -11.72M |
June 30, 2021 | -9.663M |
March 31, 2021 | -7.688M |
December 31, 2020 | -8.289M |
September 30, 2020 | -6.313M |
June 30, 2020 | -5.920M |
March 31, 2020 | -5.172M |
December 31, 2019 | -3.01M |
September 30, 2019 | -3.127M |
June 30, 2019 | -3.139M |
March 31, 2019 | -3.322M |
December 31, 2018 | -4.694M |
Date | Value |
---|---|
September 30, 2018 | -5.859M |
June 30, 2018 | -6.575M |
March 31, 2018 | -6.654M |
December 31, 2017 | -6.019M |
September 30, 2017 | -5.384M |
June 30, 2017 | -5.097M |
March 31, 2017 | -5.581M |
December 31, 2016 | -5.921M |
September 30, 2016 | -6.131M |
June 30, 2016 | -6.383M |
March 31, 2016 | -7.595M |
December 31, 2015 | -8.715M |
September 30, 2015 | -9.423M |
June 30, 2015 | -9.936M |
March 31, 2015 | -8.743M |
December 31, 2014 | -7.298M |
September 30, 2014 | -6.783M |
June 30, 2014 | -6.554M |
March 31, 2014 | -7.063M |
December 31, 2013 | -7.952M |
September 30, 2013 | -8.698M |
June 30, 2013 | -8.709M |
March 31, 2013 | -7.924M |
December 31, 2012 | -7.561M |
Free Cash Flow Range, Past 5 Years
-19.18M
Minimum
Jun 2023
-3.01M
Maximum
Dec 2019
-11.92M
Average
-12.26M
Median
Free Cash Flow Benchmarks
Perspective Therapeutics Inc | -40.58M |
Retractable Technologies Inc | -9.854M |
InfuSystems Holdings Inc | 2.464M |
Xtant Medical Holdings Inc | -17.28M |
Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.199M |
Cash from Investing (Quarterly) | -0.012M |
Cash from Financing (Quarterly) | -10.06M |
Free Cash Flow Per Share (Quarterly) | -0.0439 |
Free Cash Flow to Equity (Quarterly) | 8.768M |
Free Cash Flow Yield | -2.92% |